Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05487053

The Impact of Single-shot Adductor Canal Block Versus Continuous Femoral Nerve Block on Rehabilitation After Total Knee Replacement

The Impact of Single-shot Adductor Canal Block Versus Continuous Femoral Nerve Block on Rehabilitation After Total Knee Replacement (AdORe - ACB)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
220 (estimated)
Sponsor
Negovsky Reanimatology Research Institute · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Total knee replacement (TKR) is considered the most effective and safe method of radical treatment of late stages of knee osteoarthritis. A well-known problem of TKR is a severe postoperative pain syndrome, which is observed in more than 50% of patients. Femoral nerve block (FNB) is the "gold standard" for continuous postoperative analgesia after total knee replacement, as it is effective in reducing the frequency of use of opioid analgetics and reduce the duration of hospitalization. At the same time, the negative effect of this method is the motor blockade of the quadriceps femoris muscle which leads to functional impairment and is associated with an increased risk of falling. Adductor canal block (ACB) provides adequate analgesia comparable to femoral nerve block. Moreover, ACB doesn't affect the motor function of the quadriceps femoris muscle. The possibility of enhanced recovery after total knee replacement is the reason to compare single-shot adductor canal block and continuous femoral nerve block.

Conditions

Interventions

TypeNameDescription
PROCEDURESingle-shot adductor canal blockPostoperative analgesia in this group will be carried out by a single-shot bolus of 20 ml Ropivacaine 0.5% in the region of the middle third of the adductor canal.
PROCEDUREContinuous femoral nerve blockPostoperative analgesia in this group will be carried out by continuous infusion of local anesthetics through a catheter installed to the femoral nerve in the area of the femoral triangle. Ropivacaine 0.2% solution will be used for postoperative analgesia. Local anesthetic infusion rate is 4 ml/h to 10 ml/h.

Timeline

Start date
2024-02-03
Primary completion
2027-12-01
Completion
2028-07-01
First posted
2022-08-04
Last updated
2026-04-15

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT05487053. Inclusion in this directory is not an endorsement.